Related Experiment Videos
Evidence for familial immune defect in meningococcal meningitis
Abstract:
Twenty-six patients who had recovered from group A meningococcal meningitis were vaccinated with group C meningococcal polysaccharide and tetanus toxoid. Their haemagglutinating antibody response was measured two weeks later and compared with those of 22 siblings and 39 controls. Patients and siblings had a significantly lower antibody response to the group C vaccine but not to tetanus toxoid. This suggests that patients susceptible to meningococcal disease may have an immune defect involving their response to meningococcal polysaccharides.
Insights
Patients recovered from meningococcal meningitis showed a weaker antibody response to group C vaccines compared to controls. This suggests a potential immune defect in susceptibility to meningococcal disease.
Area of Science:
- Immunology
- Infectious Diseases
- Vaccinology
Background:
- Meningococcal meningitis remains a significant public health concern.
- Group A and Group C are common serogroups causing invasive meningococcal disease.
- Understanding immune responses post-infection is crucial for effective prevention strategies.
Purpose of the Study:
- To investigate the antibody response to meningococcal vaccines in individuals who have recovered from group A meningococcal meningitis.
- To compare the immune response of recovered patients and their siblings to healthy controls.
Main Methods:
- A cohort of 26 patients recovered from group A meningococcal meningitis was vaccinated with group C meningococcal polysaccharide and tetanus toxoid.
- Antibody titers were measured two weeks post-vaccination.
- Responses were compared to 22 siblings and 39 healthy controls.
Main Results:
- Patients and their siblings exhibited a significantly lower antibody response to the group C meningococcal polysaccharide vaccine.
- No significant difference in antibody response to tetanus toxoid was observed between groups.
- This indicates a specific defect in polysaccharide-specific antibody production.
Conclusions:
- Individuals susceptible to meningococcal disease may possess an underlying immune defect affecting their response to meningococcal polysaccharides.
- Further research is warranted to elucidate the specific immune mechanisms involved.
- This finding has implications for vaccine development and targeted prevention strategies.